Opportunity
DIBBS #SPE2DP-26-T-3643
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)
Posted
June 03, 2026
Respond By
June 08, 2026
Identifier
SPE2DP-26-T-3643
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA in Philadelphia is seeking suppliers for Moxifloxacin Hydrochloride Tablets, 400 mg, 30-count bottles, for delivery to both a US Navy vessel and a US Army facility overseas. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Total quantity: 8 bottles (5 bottles for one line item, 3 bottles for another) - Must be stored at controlled room temperature and protected from high humidity - Packaging and marking must comply with DLA packaging requirements and Medical Marking Standard No. 1A - Approved OEMs: - TEVA PHARMACEUTICALS USA, INC. (Part Number: NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (Part Number: NDC57237-0156-30) - Delivery Requirements: - Delivery required within 20 days of award (FOB destination) - Delivery locations: - USS ST LOUIS LCS 19 (FPO AA 34089) - US Army SSA 173rd Brigade, Vicenza, Italy - Notable Requirements: - Only products from the approved OEMs/part numbers are acceptable - Fast award process - Strict compliance with medical packaging and marking standards
Description
MOXIFLOXACIN HYDROC (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7017022164) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7017004670) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.